NSD1-mutant HPV-negative HNSCC tumors represent a subset of chromatin-deregulated tumors that may be more sensitive to chemoradiotherapy, albeit more resistant to immunotherapeutic interventions compared to NSD1-wild-type tumors. This evidence concerns the gene NSD1 and head and neck squamous cell carcinoma.